Trials / Completed
CompletedNCT01358695
Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet
Clinical Trial To Evaluate ANT-1207 In Subjects With Lateral Canthal Lines
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- Anterios Inc. · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ANT-1207 | The interventions differ by dose of investigational product applied. |
| BIOLOGICAL | Botulinum Toxin, Type A | The interventions differ by dose of investigational product applied. |
| BIOLOGICAL | Botulinum Toxin Type A | The interventions differ by dose of investigational product applied. |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-02-01
- Completion
- 2012-05-01
- First posted
- 2011-05-24
- Last updated
- 2013-07-01
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01358695. Inclusion in this directory is not an endorsement.